Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer. - sprookjes - yvandenbroek - TriplyDB

Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer.

Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer.

http://www.wikidata.org/entity/Q34309546

about

Shed urinary ALCAM is an independent prognostic biomarker of three-year overall survival after cystectomy in patients with bladder cancer.ALCAM is indirectly modulated by miR-125b in MCF7 cells.Key Factors in Breast Cancer Dissemination and Establishment at the Bone: Past, Present and Future Perspectives.

P2860

Q37702349-7BB1DC6F-9A11-4EA4-8F2F-94EF4D84BDB3 Q39068346-4A6FC28A-4A96-4E54-A58E-B3B551C97996 Q47250561-7F6B41A6-3386-4364-A6F4-BFCA0855BB4E

P2860

Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer.

http://www.wikidata.org/entity/Q34309546

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer.

@ast

Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer.

@en

Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer.

@nl

type

label

Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer.

@ast

Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer.

@en

Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer.

@nl

prefLabel

Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer.

@ast

Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer.

@en

Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer.

@nl

P1433

Q34309546-027B9DBE-8B78-4B47-8AE3-2D973ED8047D

P1476

Q34309546-6D2AEEA2-05D6-4DFB-B544-408146FC3CB1

P2093

Q34309546-1E75B3DC-5AA7-49D0-9613-D5F11A0B3931

Q34309546-2A369173-2925-4838-B270-270D6907AD62

Q34309546-51FAB23D-111A-4160-B2C5-1A9BCBDA10C2

Q34309546-896E411B-F9B9-41B5-94C1-3F57AC6F4324

Q34309546-8FF49B9B-0337-4BBC-8221-BAC7D8DAB138

Q34309546-C281E24E-132C-4866-A941-A479C60C44CB

Q34309546-E5976F43-7524-48E9-94AC-645EB847F70C

P2860

Q34309546-063F930F-E262-4B55-9D34-97E5414F426F

Q34309546-08067E07-BCB6-493C-B67D-88EE6F88FF74

Q34309546-088BB3DC-6B11-4B23-ADE2-95B17FEF1516

Q34309546-10C1DEC2-92B0-4245-934A-2CAA7EFC26EB

Q34309546-140B1BD9-165A-4664-9E4D-C93BA9319D9E

Q34309546-1856C649-E0A8-492A-9DA1-5240720685B9

Q34309546-19881361-059C-49C3-A2F4-0C8088C564D3

Q34309546-200632BA-AF19-4737-92A6-730BA1A86E95

Q34309546-242732FB-9728-4D76-8F25-88D3CB969A97

Q34309546-32EB6FBD-1878-4A33-AEBE-3E2FEE43BF46

P2888

Q34309546-C99B8127-809E-4C6F-A825-496B9ADD36F6

P304

Q34309546-46E325FB-E225-40A7-9E30-AC263FDD2FA2

P31

Q34309546-9CC2E264-37CE-4A9E-8BA0-D944CE7E3E6B

P356

Q34309546-C74CC286-36EA-4BEB-9F5A-41989E04BACD

P407

Q34309546-DABD50F5-8EC2-455F-89EE-B69F7C7F9B0E

P478

Q34309546-B3041BED-1F42-4F53-BD23-7F913DE9ED78

P50

Q34309546-A7E50132-BCCA-4E21-B3EB-7E59827A321E

P577

Q34309546-905D92F4-C0F5-4913-959A-304E88A4B504

P5875

Q34309546-FB16BAA5-A7CE-44B8-AEBA-9D8D9481E6CE

P6179

Q34309546-5A62FE1B-755C-4478-963D-79C6D506B54B

P698

Q34309546-9A9353E4-BF6F-4068-B2C9-D401981F90BC

P932

Q34309546-CFCB7565-AA94-464D-979F-3A6658564808

P356

1471-2407-14-715

P1433

P1476

Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer

@en

P2093

Amy L Adams

http://www.w3.org/2001/XMLSchema#string

Beverly Adade

http://www.w3.org/2001/XMLSchema#string

Fang Tan

http://www.w3.org/2001/XMLSchema#string

Marina Mosunjac

http://www.w3.org/2001/XMLSchema#string

Monica Rizzo

http://www.w3.org/2001/XMLSchema#string

Oleyad Taye

http://www.w3.org/2001/XMLSchema#string

Yijuan Hu

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand

The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression.

Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator

Cancer statistics, 2010

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Molecular portraits of human breast tumours

Stable 'portrait' of breast tumors during progression: data from biology, pathology and genetics

Characterization of mouse ALCAM (CD166): the CD6-binding domain is conserved in different homologs and mediates cross-species binding

Activated Leukocyte Cell Adhesion Molecule (ALCAM) is associated with suppression of breast cancer cells invasion.

ALCAM/CD166 protects breast cancer cells against apoptosis and autophagy.

P2888

1471-2407-14-715

P304

715

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-14-715

http://www.w3.org/2001/XMLSchema#string

P407

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Solomon F Ofori-Acquah

P577

2014-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266253175

http://www.w3.org/2001/XMLSchema#string

P6179

1010041634

http://www.w3.org/2001/XMLSchema#string

P698

25255861

http://www.w3.org/2001/XMLSchema#string

P932

4190464

http://www.w3.org/2001/XMLSchema#string